Oct 19, 2022 / 05:30AM GMT
Operator
Thank you for standing by, and welcome to the ImpediMed Limited quarterly results conference call. (Operator Instructions) I would now like to hand the conference over to Mr. Mike Bassett. Please go ahead.
Michael John Bassett - ImpediMed Limited - Senior VP of Corporate & Strategic Development and GM of Renal
Thank you, Sari. Welcome, everyone, and thank you for joining us today. We're hosting this conference call to discuss our 4C for the financial quarter ending 30 September 2022. I'm Mike Bassett, Senior Vice President of Corporate and Strategic Development. Joining us today on the call is Dave Anderson, Interim CEO; and Tim Cruickshank, our Chief Financial Officer. We'll be referring to 4C and speaking from the quarterly activity report we launched this afternoon, Australia time with the ASX. This presentation is a summary of a more detailed 4C. After our remarks, we'll be taking questions.
Before I turn over to Dave, I'd first like to bring your attention to the record that disclaimer on Page 2 of the presentation deck, the presentation deck
Q1 2023 ImpediMed Ltd Activities Report Call Transcript
Oct 19, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers